Intrinsic Value

The intrinsic value of EBR Systems Inc (EBRCZ) under the Base Case is 0.0791 USD per share. Compared with the current market price of 0.0828 USD, the stock appears Overvalued by 4% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

EBRCZ Intrinsic Value
$0.0791
Overvaluation 4%
Intrinsic Value
Price $0.0828

EBRCZ is cheaper than usual. Still overvalued, but at its cheapest valuation in the past 4 years.

Alert me when EBRCZ is below its intrinsic value
Today $0.0633 · 23.6% below the current price
Alternatives to EBRCZ

Fundamental Analysis

What EBR Systems Does

Health Care

EBR Systems develops implantable cardiac devices for patients with heart failure who need cardiac resynchronization therapy. Its main product is a wireless pacing system that helps doctors stimulate the left side of the heart without running a traditional pacing lead through the veins. The company sells this technology to hospitals and cardiac specialists who implant and manage the device for their patients.

Headquarters
United States of America US
IPO date
Nov 24, 2021
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue EBRCZ Research

Decided on EBR Systems? Get an email when EBRCZ reaches the price you’d buy at. Free with an account.

Other EBR Systems listings

What is the Intrinsic Value of one EBRCZ stock?

The intrinsic value for EBR Systems Inc (EBRCZ) under the Base Case is 0.0791 USD.

Is EBRCZ stock undervalued or overvalued?

Compared with the current market price of 0.0828 USD, the stock appears Overvalued by 4% .

How reliable are our estimates? See how past valuations played out
Back to Top